Key facts
- Local Infusion’s last known valuation is $131.0M (May 2025).
- It has raised $44.0M; the latest was Early Stage VC ($30.0M) in May 2025.
- Notable investors include PharmStars, Transformation Capital, Nashville Entrepreneur Center, blisce/, Brand Foundry Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Local Infusion
- ·The full record, as it builds
Funding rounds
No funding rounds for Local Infusion are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Local Infusion
Operator of an ambulatory infusion therapy center intended to deliver care for chronic autoimmune diseases. The company's platform aims to improve outcomes for patients, save time for physicians and make it all more affordable for everyone involved, enabling patients to make the treatment proper.
- Sector
- Healthcare
- HQ
- Concord, NH, United States
- Founded
- 2022
- Employees
- 50
- Website
- mylocalinfusion.com/
- Ownership
- Privately Held (backing)
Local Infusion doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Local Infusion shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Local Infusion in its N-PORT filings yet. We sweep new filings monthly.